首页> 外国专利> THERAPEUTIC TREATMENT OF METABOLIC SYNDROME, TYPE 2 DIABETES, OBESITY OR POTENTIAL DIABETES

THERAPEUTIC TREATMENT OF METABOLIC SYNDROME, TYPE 2 DIABETES, OBESITY OR POTENTIAL DIABETES

机译:代谢综合征,2型糖尿病,肥胖或潜在糖尿病的治疗

摘要

FIELD: medicine.;SUBSTANCE: invention refers to medicine. A method of treating a patient suffering a metabolic disorder involves the stage of introducing into a patient suffering metabolic syndrome a pharmaceutical composition containing (1) at least one compound which stimulates higher activity of central dopaminergic neurons in said subject, and (2) at least one compound which stimulates lower activity of central noradrenergic neurons in said subject wherein the relation of said at least one compound which stimulates higher activity of central dopaminergic neurons to said at least one compound which stimulates lower activity of central noradrenergic neurons in said pharmaceutical composition makes approximately 500:1 to 1:500 at weight to weight basis (wt:wt).;EFFECT: higher clinical effectiveness.;24 cl, 14 ex
机译:领域:药物;物质:发明是指药物。治疗患有代谢紊乱的患者的方法包括以下步骤:将药物组合物引入患有代谢综合征的患者,所述药物组合物包含(1)至少一种在所述受试者中刺激中枢多巴胺能神经元更高活性的化合物,和(2)至少一种在所述受试者中刺激中枢去甲肾上腺素能神经元活性降低的化合物,其中所述至少一种在中枢多巴胺能神经元中刺激更高活性的化合物与所述至少一种在所述药物组合物中刺激中枢去甲肾上腺素能神经元活性的化合物的关系使得500:1至1:500,以重量对重量计(wt:wt).;效果:更高的临床疗效;; 24 cl,14 ex

著录项

  • 公开/公告号RU2467743C2

    专利类型

  • 公开/公告日2012-11-27

    原文格式PDF

  • 申请/专利权人 VEROSAJENS EHLEHLSI;

    申请/专利号RU20090148809

  • 发明设计人 KINKOTTA EHNTONI KH. (US);

    申请日2008-05-29

  • 分类号A61K31/13;A61K31/137;A61P3;A61P5;

  • 国家 RU

  • 入库时间 2022-08-21 16:23:18

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号